Comparison between Gujarat Kidney IPO and Pace Digitek IPO.
Gujarat Kidney IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Pace Digitek IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Gujarat Kidney IPO is up to ₹250.80 Cr whereas the issue size of the Pace Digitek IPO is up to ₹819.15 Cr. The final issue price of Gujarat Kidney IPO is ₹114.00 per share and of Pace Digitek IPO is ₹219.00 per share.
| Gujarat Kidney IPO | Pace Digitek IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹2 per share |
| Issue Price (Lower) | ₹108.00 per share | ₹208.00 per share |
| Issue Price (Upper) | ₹114.00 per share | ₹219.00 per share |
| Issue Price (Final) | ₹114.00 per share | ₹219.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹20.00 per share | |
| Market Lot Size | 128 shares | 68 shares |
| Fresh Issue Size | 2,20,00,000 shares | 3,74,09,047 shares |
| Fresh Issue Size (Amount) | up to ₹250.80 Cr | up to ₹819.15 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 2,20,00,000 shares | 3,74,09,047 shares |
| Issue Size Total (Amount) | up to ₹250.80 Cr | up to ₹819.15 Cr |
Gujarat Kidney IPO opens on Dec 22, 2025, while Pace Digitek IPO opens on Sep 26, 2025. The closing date of Gujarat Kidney IPO and Pace Digitek IPO is Dec 24, 2025, and Sep 30, 2025, respectively.
| Gujarat Kidney IPO | Pace Digitek IPO | |
|---|---|---|
| Anchor Bid Date | Dec 19, 2025 | Sep 25, 2025 |
| Issue Open | Dec 22, 2025 | Sep 26, 2025 |
| Issue Close | Dec 24, 2025 | Sep 30, 2025 |
| Basis Of Allotment (Tentative) | Dec 26, 2025 | Oct 01, 2025 |
| Initiation of Refunds (Tentative) | Dec 29, 2025 | Oct 03, 2025 |
| Credit of Share (Tentative) | Dec 29, 2025 | Oct 03, 2025 |
| Listing date (Tentative) | Dec 30, 2025 | Oct 06, 2025 |
| Anchor Lockin End date 1 | Jan 24, 2026 | Oct 30, 2025 |
| Anchor Lockin End date 2 | Mar 25, 2026 | Dec 29, 2025 |
Gujarat Kidney IPO P/E ratio is 61.62, as compared to Pace Digitek IPO P/E ratio of 14.
| Gujarat Kidney IPO | Pace Digitek IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Gujarat Kidney & Super Speciality Ltd.'s revenue increased by 637% and profit after tax (PAT) rose by 454% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Pace Digitek Ltd.'s revenue not changed and profit after tax (PAT) rose by 21% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.1 | 84.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.45 | 69.5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 61.62 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹898.81 Cr. | ₹4727.03 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 36.61% | 23.09% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 37.65% | 37.89% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.15 | 0.13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.85 | ₹15.64 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.61% | 22.87% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Gujarat Kidney IPO Retail Individual Investors (RII) are offered 22,00,000 shares while in Pace Digitek IPO retail investors are offered 22,00,000 shares. Qualified Institutional Buyers (QIB) are offered 77,26,880 shares in Gujarat Kidney IPO and 74,62,539 shares in Pace Digitek IPO.
| Gujarat Kidney IPO | Pace Digitek IPO | |
|---|---|---|
| Anchor Investor Reservation | 87,73,120 shares | 1,11,93,807 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 77,26,880 shares | 74,62,539 shares |
| NII | 33,00,000 shares | 55,96,905 shares |
| RII | 22,00,000 shares | 1,30,59,443 shares |
| Employee | 0 shares | 1,00,502 shares |
| Others | ||
| Total | 2,20,00,000 shares | 3,74,13,196 shares |
Gujarat Kidney IPO subscribed 5.21x in total, whereas Pace Digitek IPO subscribed 1.68x.
| Gujarat Kidney IPO | Pace Digitek IPO | |
|---|---|---|
| QIB (times) | 1.06x | 1.69x |
| NII (times) | 5.73x | 3.06x |
| Big NII (times) | 5.25x | 3.25x |
| Small NII (times) | 6.68x | 2.66x |
| RII (times) | 19.04x | 1.09x |
| Employee (times) | 1.83x | |
| Other (times) | ||
| Total (times) | 5.21x | 1.68x |
